High-throughput screening for Hsp90 ATPase inhibitors

Bioorganic and Medicinal Chemistry Letters

Volumn 16, Issue 11, 2006, Pages 3005-3008

  Avila, Christopher ^a   Hadden, M Kyle ^a   Ma, Zeqiang ^a   Kornilayev, Boris A ^a   Ye, Qi Zhuang ^a   Blagg, Brian S J ^a  

^a UNIVERSITY OF KANSAS   (United States)

Author keywords

High throughput screening; Hsp90; Inhibitors

Indexed keywords

HEAT SHOCK PROTEIN 90; HEAT SHOCK PROTEIN 90 INHIBITOR;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; FEASIBILITY STUDY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IC 50; REPRODUCIBILITY; STRUCTURE ACTIVITY RELATION;

ADENOSINE TRIPHOSPHATASES; ENZYME INHIBITORS; HSP90 HEAT-SHOCK PROTEINS; MOLECULAR STRUCTURE;

EID: 33646036989     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2006.02.063     Document Type: Article

References (37)

1. Workman P. Trends Mol. Med. 10 (2004) 47
2. Chiosis G., Vilenchik M., Kim J., and Solit D. Drug Discovery Today 9 (2004) 881
3. Sreedhar A.S., Soti C., and Csermely P. Biochim. Biophys. Acta 1697 (2004) 233
4. Zhang H., and Burrows F. Mol. Med. 82 (2004) 488
5. Neckers L. Trends Mol. Med. 8 (2002) S55
6. Adams J., and Elliot P. J. Oncogene 19 (2000) 6687
7. Csermely P., Schnaider T., Soti C., Prohaszka Z., and Nardai G. Pharmacol. Ther. 79 (1998) 129
8. Goetz M.P., Toft D.O., Ames M.M., and Erlichman C. Ann. Oncol. 14 (2003) 1169
9. Richter K., and Buchner J. J. Cell. Physiol. 188 (2001) 281
10. Ratajczak T., and Carrello A. J. Biol. Chem. 271 (1996) 2961
11. Picard D. Cell. Mol. Life Sci. 59 (2002) 1640
12. Panaretou B., Prodromou C., Roe S.M., O'Brien R., Ladbury J.E., Piper P.W., and Pearl L.H. EMBO J. 17 (1998) 4829
13. Eleuteri A.M., Cuccioloni M., Bellesi J., Lupidi G., Fioretti E., and Angeletti M. Proteins: Struct. Funct. Genet. 48 (2002) 169
14. Whitesell L., Mimnaugh E.G., De Costa B., Myers C.E., and Neckers L.M. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8324
15. Dikalov S., Rumyantseva G.V., Piskunov A.V., and Weiner L.M. Biochemistry 31 (1992) 8947
16. Schnur R.C., and Corman M.L. J. Org. Chem. 59 (1994) 2581
17. Rinehart K.L., and Shield L.S. Fortschr. Chem. Org. Naturst. 33 (1976) 231
18. Supko J.G., Hickman R.L., Grever M.R., and Malspeis L. Cancer Chemother. Pharmacol. 36 (1995) 305
19. Roe S.M., Prodromou C., O'Brien R., Ladbury J.E., Piper P.W., and Pearl L.H. J. Med. Chem. 42 (1999) 260
20. Schulte T.W., Akinaga S., Soga S., Sullivan W., Stensgard B., Toft D., and Neckers L.M. Cell Stress Chaperones 3 (1998) 100
21. Cutler H.G., Arrendale R.F., Springer J.P., Cole P.D., Roberts R.G., and Hanlin R.T. Agric. Biol. Chem. 51 (1987) 3331
22. Kamal A., Thao L., Sensintaffar J., Zhang L., Boehm M.F., Fritz L.C., and Burrows F.J. Nature 425 (2003) 407
23. Sausville E.A. Curr. Cancer Drug Targets 3 (2003) 377
24. Schulte T.W., and Neckers L.M. Cancer Chemother. Pharmacol. 42 (1998) 273
25. Jez J.M., Chen J.C.-H., Rastelli G., Stroud R.M., and Santi D.V. Chem. Biol. 10 (2003) 361
26. Egorin M.J., Lagattuta T.F., Hamburger D.R., Covey J.M., White K.D., Musser S.M., and Eiseman J.L. Cancer Chemother. Pharmacol. 49 (2002) 7
27. Zhou M., Diwu Z., Panchuk-Voloshina N., and Haugland R.P. Anal. Biochem. 253 (1997) 162
28. Mohanty J.G., Jaffe J.S., Schulman E.S., and Raible D.G. J. Immunol. Methods 202 (1997) 133
29. Avila C., Kornilayev B.A., and Blagg B.S. J. Bioorg. Med. Chem. 14 (2006) 1134
30. Optimal Conditions in 384-well plate: Glucose oxidase (4 U/mL), maltose phosphorylase (2 U/mL), maltose (0.2 mM), amplex red (50 μM), horseradish peroxidase (0.2 U/mL), ATP (1.5 mM), and Hsp90 (50 μg/mL) were combined to total of 50 μL and incubated for 3 h at 37 °C and the absorbance of the resorufin product was measured at 563 nm.
31. Zhang J.H., Cheung T.D., and Oldenburg K.R. J. Biomol. Screen. 4 (1999) 67
32. Control conditions: Glucose oxidase (4 U/mL), maltose phosphorylase (2 U/mL), maltose (0.2 mM), amplex red (50 μM), horseradish peroxidase (0.2 U/mL) Hsp90 (50 μg/mL), compound (20 μg/mL), and inorganic phosphate (100 μM) were combined and incubated for 3 h at 37 °C and the absorbance of resorufin was measured at 563 nm.
33. Dymock B.W., Barril X., Brough P.A., Cansfield J.E., Massey A., McDonald E., Hubbard R.E., Surgenor A., Roughley S.D., Webb P., Workman P., Wright L., and Drysdale M.J. J. Med. Chem. 48 (2005) 4212
34. Kreusch A., Han S., Brinker A., Zhou V., Choi H.-S., He Y., Lesley S.A., Caldwell J., and Gu X.-J. Bioorg. Med. Chem. Lett. 15 (2005) 1475
35. Barril X., Brough P., Drysdale M., Hubbard R.E., Massey A., Surgenor A., and Wright L. Bioorg. Med. Chem. Lett. 15 (2005) 5187
36. Huezo H., Vilenchik M., Rosen N., and Chiosis G. Chem. Biol. 10 (2003) 629
37. Chiosis G., Lucas B., Shtil A., Huezo H., and Rosen N. Bioorg. Med. Chem. 10 (2002) 3555